Indications for Starting Norepinephrine
Norepinephrine should be initiated when hypotension persists despite adequate fluid resuscitation, specifically targeting a mean arterial pressure (MAP) of 65 mmHg or higher.
Primary Clinical Indications
Septic Shock
Norepinephrine is the first-choice vasopressor for septic shock after initial fluid resuscitation 1. The specific algorithm is:
- First, give fluids: Administer at least 30 mL/kg of crystalloids for suspected hypovolemia
- Then start norepinephrine: If hypotension persists despite fluid resuscitation
- Target MAP ≥65 mmHg as the initial hemodynamic goal
This represents a strong recommendation with moderate quality evidence from the 2016 Surviving Sepsis Campaign guidelines 1.
Cardiogenic Shock (Acute MI)
In acute myocardial infarction complicated by cardiogenic shock, use the minimum necessary dose of vasopressor to maintain MAP >65 mmHg, favoring norepinephrine as first-line therapy 2. Start norepinephrine when:
- Hypotension persists after initial stabilization measures
- Blood pressure is inadequate to maintain organ perfusion
- The patient requires hemodynamic support during or after coronary intervention
Important caveat: In previously hypertensive patients, raise blood pressure no higher than 40 mmHg below their pre-existing systolic pressure 3.
Critical Timing Consideration
Blood volume depletion must be corrected as fully as possible before starting norepinephrine 3. However, when cerebral or coronary artery ischemia is imminent as an emergency measure, norepinephrine can be administered before and concurrently with blood volume replacement 3.
Specific Clinical Scenarios Where Norepinephrine is Preferred
When to Choose Norepinephrine Over Alternatives:
- Default choice: Use as first-line vasopressor in shock states 1
- Avoid dopamine: Only consider dopamine in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia 1
- Avoid phenylephrine: Reserve for specific circumstances like serious arrhythmias with norepinephrine, known high cardiac output with persistent low blood pressure, or salvage therapy 1
Alternative Agents May Be Preferred When:
- Unstable bradycardia: Consider dopamine or epinephrine for increased chronotropic effect 2
- Dynamic LV outflow tract obstruction: Use pure vasopressors like phenylephrine or vasopressin 2
- Refractory hypoxemia or acidosis: Catecholamine efficacy may be attenuated; favor vasopressin 2
Practical Starting Parameters
Initial Dosing (per FDA label):
- Starting rate: 2-3 mL/minute of diluted solution (8-12 mcg/minute of base) 3
- Standard dilution: 4 mg in 1000 mL of 5% dextrose (4 mcg/mL) 3
- Maintenance range: 0.5-1 mL/minute (2-4 mcg/minute of base) 3
- Titrate to effect: Adjust based on blood pressure response
Administration Requirements:
- Route: Large vein preferred, though peripheral administration is possible with appropriate monitoring 4, 5
- Monitoring: Arterial catheter placement recommended as soon as practical for all patients requiring vasopressors 1
- Dilution: Must be diluted in dextrose-containing solutions; saline alone is not recommended 3
Common Pitfalls to Avoid
Do not use norepinephrine for renal protection - this is ineffective and represents misuse of the agent 1.
Do not delay fluid resuscitation - occult blood volume depletion should always be suspected and corrected when patients require escalating doses 3. Central venous pressure monitoring helps detect this situation 3.
Do not use as monotherapy without addressing underlying cause - norepinephrine supports blood pressure while definitive treatment (source control in sepsis, revascularization in MI) is pursued 1, 2.